Cibus (CBUS) Q2 FY26 earnings call

Cibus is sharpening its strategic focus under new CEO Craig Wichner, emphasizing capital discipline and near-term revenue generation from its scalable gene-editing platform. The company is leveraging favorable regulatory environments in Europe and Latin America to advance its pipeline, particularly in sustainable ingredients and rice, despite a revised timeline for its rice commercial launch. Management is prioritizing resource allocation to drive growth while continuing to reduce non-core costs.